February is Black History Month, a time to celebrate the achievements, resilience, and lasting impact of Black leaders across every field, including medicine and clinical research. At Tekton Research, we take this opportunity to reflect on the pioneers whose contributions have shaped the medical world and the lessons their stories teach us about ethics, trust, and progress.
The Legacy of Dr. Solomon Carter Fuller
One of the stories that continues to inspire the medical community is that of Dr. Solomon Carter Fuller. Dr. Fuller was a neurologist, psychiatrist, and research scientist. At just 25 years old, Dr. Fuller became the nation’s first Black psychiatrist.
Dr. Fuller worked alongside Dr. Alois Alzheimer and played a critical role in the earliest research on what is now known as Alzheimer’s disease. His contributions helped lay the foundation for today’s understanding of neurodegenerative disorders.
Some of his key accomplishments include:
- Translating and publishing Dr. Alois Alzheimer’s original research into English, helping introduce foundational findings on Alzheimer’s disease to the United States.
- Conducting independent neuropathological research on brain degeneration, plaques, and neurofibrillary changes associated with cognitive decline.
- Teaching and mentoring medical students in neurology and psychiatry at Boston University for more than three decades.
Advancing Equity in Medical Education
Beyond his scientific achievements, Dr. Fuller was deeply committed to expanding access to medical education. At a time when racial discrimination limited professional advancement for Black physicians, he served on the faculty at Boston University School of Medicine and helped open pathways for Black medical students to pursue advanced psychiatric training.
He championed rigorous academic standards in psychiatry, emphasizing scientific research, careful clinical observation, and compassionate, humane treatment of participants. His dedication to both excellence and opportunity left a lasting mark on medical education and professional development.
Dr. Fuller’s legacy endures not only in Alzheimer’s research but also in his efforts to promote access, integrity, and higher standards in medicine.
Carrying Forward a Legacy of Inclusion
Dr. Fuller’s commitment to equity and excellence continues to resonate today. In that same spirit, Tekton Research is dedicated to advancing equity and inclusion in clinical research—ensuring diverse patient populations are represented, reducing barriers to participation, and expanding access to innovative care opportunities for historically underrepresented communities.
Just as Dr. Fuller championed opportunity and elevated standards in medicine despite systemic obstacles, Tekton remains committed to conducting research that is both scientifically rigorous and intentionally inclusive—helping move healthcare forward for all.
Honoring the Past, Building the Future
This Black History Month, we honor Dr. Fuller and the countless Black patients, physicians, researchers, and healthcare leaders whose contributions have shaped medicine and clinical research. Their stories inspire us to uphold the highest ethical standards, drive innovation responsibly, and work toward greater health equity for all communities.
At Tekton Research, we are proud to carry forward their legacy and continue building a future where research is conducted with integrity, trust, and respect for every participant.